Literature DB >> 28922349

Cytochrome P450 and flavin-containing monooxygenase families: age-dependent differences in expression and functional activity.

Nicole R Zane1, Yao Chen2, Michael Zhuo Wang2, Dhiren R Thakker1.   

Abstract

BackgroundAge-dependent differences in pharmacokinetics exist for metabolically cleared medications. Differential contributions in the cytochrome P450 3A (CYP3A), CYP2C, and flavin-containing monooxygenases (FMOs) families have an important role in the metabolic clearance of a large number of drugs administered to children.MethodsUnlike previous semiquantitative characterization of age-dependent changes in the expression of genes and proteins (western blot analysis), this study quantifies both gene and absolute protein expression in the same fetal, pediatric, and adult hepatic tissue. Expression was then correlated with the corresponding functional activities in the same samples.ResultsCYP3A and FMO families showed a distinct switch from fetal (CYP3A7 and FMO1) to adult isoforms (CYP3A4 and FMO3) at birth, whereas CYP2C9 showed a linear maturation from birth into adulthood. In contrast, analysis of CYP2C19 revealed higher expression and catalytic efficiency in pediatric samples compared with that in fetal and adult samples. Further, CYP3A and FMO enzymes exhibited an unexpectedly higher functional activity in fetal samples not entirely explained by protein expression.ConclusionThese surprising findings suggest that CYP and FMO enzymes may encounter development-related differences in their microenvironments that can influence the enzyme activity in addition to protein expression levels.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28922349     DOI: 10.1038/pr.2017.226

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  38 in total

Review 1.  The roles of cytochrome b5 in cytochrome P450 reactions.

Authors:  Todd D Porter
Journal:  J Biochem Mol Toxicol       Date:  2002       Impact factor: 3.642

2.  Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection.

Authors:  Hirotaka Kawakami; Sumio Ohtsuki; Junichi Kamiie; Takashi Suzuki; Takaaki Abe; Tetsuya Terasaki
Journal:  J Pharm Sci       Date:  2010-06-16       Impact factor: 3.534

3.  Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.

Authors:  Agnès Tran; Elisabeth Rey; Gérard Pons; Ann Pariente-Khayat; Philippe D'Athis; Valentine Sallerin; Christophe Dupont
Journal:  Clin Pharmacol Ther       Date:  2002-05       Impact factor: 6.875

4.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

Authors:  D Lacroix; M Sonnier; A Moncion; G Cheron; T Cresteil
Journal:  Eur J Biochem       Date:  1997-07-15

5.  In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Joseph G Ibrahim; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

6.  A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes.

Authors:  Michael Zhuo Wang; Judy Qiju Wu; Jennifer B Dennison; Arlene S Bridges; Stephen D Hall; Sally Kornbluth; Richard R Tidwell; Philip C Smith; Robert D Voyksner; Mary F Paine; James Edwin Hall
Journal:  Proteomics       Date:  2008-10       Impact factor: 3.984

7.  Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Arlene Bridges; Yan Gao; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2008-03-24       Impact factor: 3.922

Review 8.  Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans.

Authors:  J R Cashman; S B Park; C E Berkman; L E Cashman
Journal:  Chem Biol Interact       Date:  1995-04-28       Impact factor: 5.192

9.  Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6.

Authors:  Xuan Chen; Li Qiang Pan; Hua Naranmandura; Su Zeng; Shu Qing Chen
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

Review 10.  Pharmacogenomics of human P450 oxidoreductase.

Authors:  Amit V Pandey; Patrick Sproll
Journal:  Front Pharmacol       Date:  2014-05-09       Impact factor: 5.810

View more
  16 in total

Review 1.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

Review 2.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 3.  Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Brian T Fisher
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938

4.  Overexpression of the salicylic acid binding protein 2 (SABP2) from tobacco enhances tolerance against Huanglongbing in transgenic citrus.

Authors:  Juliana M Soares; Kyle C Weber; Wenming Qiu; Lamiaa M Mahmoud; Jude W Grosser; Manjul Dutt
Journal:  Plant Cell Rep       Date:  2022-09-15       Impact factor: 4.964

5.  Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.

Authors:  Md Kabir; Elias C Padilha; Pranav Shah; Ruili Huang; Srilatha Sakamuru; Eric Gonzalez; Lin Ye; Xin Hu; Mark J Henderson; Menghang Xia; Xin Xu
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

Review 6.  Voriconazole: A Review of Population Pharmacokinetic Analyses.

Authors:  Changcheng Shi; Yubo Xiao; Yong Mao; Jing Wu; Nengming Lin
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

Review 7.  PharmVar GeneFocus: CYP2C19.

Authors:  Mariana R Botton; Michelle Whirl-Carrillo; Andria L Del Tredici; Katrin Sangkuhl; Larisa H Cavallari; José A G Agúndez; Jorge Duconge; Ming Ta Michael Lee; Erica L Woodahl; Karla Claudio-Campos; Ann K Daly; Teri E Klein; Victoria M Pratt; Stuart A Scott; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2020-07-22       Impact factor: 6.875

Review 8.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

Review 9.  PharmVar GeneFocus: CYP2C9.

Authors:  Katrin Sangkuhl; Karla Claudio-Campos; Larisa H Cavallari; Jose A G Agundez; Michelle Whirl-Carrillo; Jorge Duconge; Andria L Del Tredici; Mia Wadelius; Mariana Rodrigues Botton; Erica L Woodahl; Stuart A Scott; Teri E Klein; Victoria M Pratt; Ann K Daly; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2021-07-12       Impact factor: 6.903

Review 10.  Ontogeny of Drug-Metabolizing Enzymes.

Authors:  Aarzoo Thakur; Md Masud Parvez; J Steven Leeder; Bhagwat Prasad
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.